How does a new medicine perform once it is used in everyday clinical practice after approval? This is the question being investigated jointly by the…
Study by the German Centre for Cardiovascular Research (DZHK), led by LMU University Hospital Munich, demonstrates for the first time benefits in hard…
Heidelberg-based biotech company REVIER Therapeutics has officially launched. The company, which emerged from research conducted at the German Centre…
A recent review led by University Medical Center Mainz, a partner site of the DZHK, compares the effects of cigarettes, waterpipes, heated tobacco…
People with type 2 diabetes and obesity may benefit from treatment with tirzepatide. Tirzepatide, marketed under the brand name Mounjaro, can reduce…
The MagMa study by the DHZC, involving DZHK researchers, shows for the first time in a prospective study that radiation-free magnetocardiography can…